Why the study?
Does valve replacement (TAVR or SAVR) improve 1-year survival compared to balloon aortic valvuloplasty in patients with end-stage renal disease and severe aortic stenosis?
Population
85 patients with end-stage renal disease (ESRD) and severe aortic stenosis (AS)
Comparison
Transcatheter aortic valve replacement or… vs Balloon aortic valvuloplasty (BAV) only
Design
Cohort
Follow-up
1 year
Authors
Loading...
Valve replacement associated with lower 1-year mortality than BAV in ESRD with severe AS; leaves open need for randomized confirmation.
Does valve replacement (TAVR or SAVR) improve 1-year survival compared to balloon aortic valvuloplasty in patients with end-stage renal disease and severe aortic stenosis?
In patients with end-stage renal disease and severe aortic stenosis, definitive valve replacement (TAVR or SAVR) is associated with significantly higher 1-year survival compared to balloon aortic valvuloplasty alone.
Condado et al. (2017) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: